
Dr Gen Li
Dr Gen Li is a pharmaceutical industry leader with a passion to improve patients’ lives. Prior to founding Phesi in 2007, Dr Li was Head of Productivity for Pfizer Worldwide Clinical Development, a position he assumed following Pfizer’s acquisition of Pharmacia, where he delivered the first implementation of productivity measurement for clinical development. While at Pharmacia and Pfizer, Dr Li significantly contributed to the Centre for Medicines Research (CMR) International database for pharmaceutical R&D performance, assuring the collection of key clinical trial parameters as representative of the critical path for delivery. He was also instrumental in creating the KMR productivity model. Previously, Dr Li led the creation of the first computer-automated resource management system at Bristol-Myers Squibb. Dr Li received the prestigious Upjohn Award from Pfizer/Pharmacia. He earned his PhD in Biochemistry from Beijing University and an MBA from the Johnson Graduate School of Management at Cornell University.
Contact info
- Website:
- https://www.phesi.com/
ArticleFrom constraint to catalyst: innovation in rare disease clinical development
Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence generation, trial design and regulatory thinking that could influence the future of clinical development.


